This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations by Daniel R McMasters in RNA Viral Infection Treatment
Introduction
Daniel R McMasters is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of RNA-dependent RNA viral infections. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Daniel R McMasters holds a patent for "Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection." This invention provides ribonucleoside 2',3'-cyclic acetals that serve as precursors or prodrugs of inhibitors targeting RNA-dependent RNA viral polymerase. These compounds are particularly effective in treating hepatitis C virus (HCV) infections by inhibiting HCV replication.
Career Highlights
Daniel is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on developing innovative solutions for viral infections, contributing to advancements in medical treatments.
Collaborations
Daniel has collaborated with notable colleagues, including Gabor Butora and Kenneth Alan Koeplinger. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical industry.
Conclusion
Daniel R McMasters is a prominent inventor whose work in RNA viral infection treatment exemplifies innovation in the pharmaceutical field. His contributions continue to impact the development of effective therapies for viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile